Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Talphera, Inc.

Report top-line data from the NEPHRO registration trial

Not delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
22 Jan 2024
Due
30 Sep 2024
Checked
22 Sep 2026
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“Talphera expects the top-line data read-out of its NEPHRO registration trial in the third quarter of 2024”
  • SourceTalphera, Inc. Form 8-K press release, 2024-01-22
  • FilingSEC filing index
  • Deadline as statedin the third quarter of 2024
  • Deadline used30 Sep 2024, the last day of the stated period
  • TypeProject
  • Permanent referenceKI-C-2024-TLPH-000053
    Cite as https://keptindex.org/c/KI-C-2024-TLPH-000053/ — this address never changes.

What we found

Evidence strength A What the grades mean

Talphera announced revised timeline in Q1 2024 indicating Q3 2024 top-line data goal would likely be revised; study remained in enrollment phase through 2024 with completion expected 2025.

  • A
    Q4 2024 Financial Results Regulatory filing · published 31 Mar 2025 · retrieved 22 Sep 2026 · kept permanently by the SEC · fingerprint 9fa8b8ae4fbc Company expected NEPHRO CRRT study completion by end of 2025, not Q3 2024
  • D
    Q1 2024 Earnings Report - Talphera Other source · published 14 May 2024 · retrieved 22 Sep 2026 · fingerprint 1b56972410e6 Management stated Q3 2024 top-line data goal would likely be revised due to enrollment delays
  • D
    Q3 2024 Earnings Results Other source · published 14 Nov 2024 · retrieved 22 Sep 2026 Five sites screening patients with completion aiming for 2025, confirming no Q3 2024 data

Checked 22 Sep 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical readout
Indicative materiality
Medium rules
Action
Report
Language
Expected (“expects”, “plans”)

How this entry was checked

  1. Commitment recordedRecorded from the company's filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
  4. Third check on a negative finding: agreesBecause a negative finding could harm a company if wrong, a stronger model re-read the evidence fully blind and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Talphera, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2024-TLPH-000053 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.